Logo do repositório
 
Publicação

Topical review: studies on management of myopia progression from 2019 to 2021

2023-01Artigo científico Acesso aberto
Ver registo simples
dc.contributor.authorLança, Carla
dc.contributor.authorRepka, Michael X.
dc.contributor.authorGrzybowski, Andrzej
dc.date.accessioned2022-12-15T11:40:47Z
dc.date.available2024-12-15T01:30:21Z
dc.date.issued2023-01
dc.description.abstractMyopia is a common eye condition that increases the risk of sight-threatening complications. Each additional diopter increases the chance of complications. The purpose of this review is to make an overview of myopia control treatment options for children with myopia progression. In this non-systematic review, we searched PubMed and Cochrane databases for English-language studies published from 2019 through September 2021. Emphasis was given to a selection of randomized controlled trials. Nineteen randomized controlled trials and two retrospective studies were included. Topical atropine and orthokeratology remain the most used treatments, while lenses with novel designs are emerging treatments. Overall myopia progression in the treatment groups for low-dose atropine and orthokeratology were lower than in the control groups and their efficacy was reported in several randomized controlled trials and confirmed by various systematic reviews and meta-analysis. The findings of myopia progression and axial elongation for the MiSight, defocus incorporated multiple segments spectacle lens, highly aspherical lenslets and diffusion optics technology spectacle lens was comparable. Public health interventions to optimize environmental influences may also be important strategies to control myopia. The optimal choice of management of myopia depends on treatment availability, acceptability to the child and parents, and specific patient features such as age, baseline myopia, and lifestyle. Eye care providers need to understand the advantages and disadvantages of each therapy to best counsel parents of children with myopia.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationLança CC, Repka MX, Grzybowski A. Topical review: studies on management of myopia progression from 2019 to 2021. Optom Vis Sci. 2023;100(1):23-30.pt_PT
dc.identifier.doi10.1097/OPX.0000000000001947pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.21/15154
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherWolters Kluwerpt_PT
dc.relation.publisherversionhttps://journals.lww.com/optvissci/Abstract/9900/Topical_Review__Studies_on_Management_of_Myopia.43.aspxpt_PT
dc.subjectOphthalmologypt_PT
dc.subjectMyopiapt_PT
dc.subjectChildrenpt_PT
dc.subjectNon-systematic reviewpt_PT
dc.titleTopical review: studies on management of myopia progression from 2019 to 2021pt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage30pt_PT
oaire.citation.issue1pt_PT
oaire.citation.startPage23pt_PT
oaire.citation.titleOptometry and Vision Sciencept_PT
oaire.citation.volume100pt_PT
person.familyNameLança
person.givenNameCarla
person.identifier.ciencia-id601A-6412-BF2F
person.identifier.orcid0000-0001-9918-787X
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication0320b455-ee19-4670-8bf2-10dce9de1bec
relation.isAuthorOfPublication.latestForDiscovery0320b455-ee19-4670-8bf2-10dce9de1bec

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
Topical review_studies on management of myopia progression from 2019 to 2021.pdf
Tamanho:
1.22 MB
Formato:
Adobe Portable Document Format
Ver/Abrir
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Ver/Abrir

Coleções

ESTeSL - Artigos